Cytek Biosciences (CTKB) Tax Provisions (2020 - 2026)

Cytek Biosciences' Tax Provisions history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Tax Provisions rose 1002.94% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.0 million (up 1050.3% YoY) and the FY2025 annual result came in at $36.7 million, up 11368.12% from the prior year.
• Tax Provisions was $1.5 million for Q1 2026 at Cytek Biosciences, down from $40.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $40.0 million in Q4 2025 and bottomed at -$2.8 million in Q1 2024.
• A 5-year average of $2.0 million and a median of -$699000.0 in 2022 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2022 — Tax Provisions tumbled 2390.0% — and 2025, when it soared 5455.28%.
• Cytek Biosciences' Tax Provisions stood at $396000.0 in 2022, then plunged by 451.52% to -$1.4 million in 2023, then surged by 151.72% to $720000.0 in 2024, then surged by 5455.28% to $40.0 million in 2025, then plunged by 96.25% to $1.5 million in 2026.
• Business Quant data shows CTKB's Tax Provisions at $1.5 million in Q1 2026, $40.0 million in Q4 2025, and -$2.3 million in Q3 2025.